Langerin+ dermal dendritic cells are critical for CD8 + T cell activation and IgH γ-1 class switching in response to gene gun vaccines

Journal of Immunology

Volumn 186, Issue 3, 2011, Pages 1377-1383

  Stoecklinger, Angelika ^a   Eticha, Tekalign D ^a   Mesdaghi, Mehrnaz ^a   Kissenpfennig, Adrien ^b   Malissen, Bernard ^c   Thalhamer, Josef ^a   Hammerl, Peter ^a  

^a UNIVERSITY OF SALZBURG   (Austria)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; DIPHTHERIA TOXIN; DIPHTHERIA TOXIN RECEPTOR; GAMMA INTERFERON; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 4; LANGERIN; RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL MIGRATION; CELL SUBPOPULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOLYSIS; DENDRITIC CELL; GENE GUN IMMUNIZATION; GENE TARGETING; HELPER CELL; HUMORAL IMMUNITY; IMMUNOGLOBULIN PRODUCTION; INTERFERON PRODUCTION; LYMPH NODE; MOUSE; NONHUMAN; POLARIZATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN INDUCTION; SKIN CELL; SPLEEN CELL; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGENS, CD; ANTIGENS, SURFACE; BIOLISTICS; CD8-POSITIVE T-LYMPHOCYTES; CELL DEATH; CELL DIFFERENTIATION; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; IMMUNOGLOBULIN GAMMA-CHAINS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN SWITCH REGION; LECTINS, C-TYPE; LYMPHOCYTE ACTIVATION; MANNOSE-BINDING LECTINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; SKIN; T-LYMPHOCYTES, HELPER-INDUCER; VACCINES, DNA;

EID: 79251588742     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1002557     Document Type: Article

References (51)

1. Liu, K., and M. C. Nussenzweig. 2010. Origin and development of dendritic cells. Immunol. Rev. 234: 45-54.
2. Romani, N., B. E. Clausen, and P. Stoitzner. 2010. Langerhans cells and more: langerin-expressing dendritic cell subsets in the skin. Immunol. Rev. 234: 120-141.
3. Romani, N., S. Holzmann, C. H. Tripp, F. Koch, and P. Stoitzner. 2003. Langerhans cells: dendritic cells of the epidermis. APMIS 111: 725-740.
4. Schuler, G., and R. M. Steinman. 1985. Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. J. Exp. Med. 161: 526-546.
5. Steinman, R. M., and Z. A. Cohn. 1973. Identification of a novel cell type in peripheral lymphoid organs of mice, I: Morphology, quantitation, tissue distribution. J. Exp. Med. 137: 1142-1162.
6. Valladeau, J., V. Duvert-Frances, J. J. Pin, C. Dezutter-Dambuyant, C. Vincent, C. Massacrier, J. Vincent, K. Yoneda, J. Banchereau, C. Caux, et al. 1999. The monoclonal antibody DCGM4 recognizes Langerin, a protein specific of Langerhans cells, and is rapidly internalized from the cell surface. Eur. J. Immunol. 29: 2695-2704.
7. Valladeau, J., O. Ravel, C. Dezutter-Dambuyant, K. Moore, M. Kleijmeer, Y. Liu, V. Duvert-Frances, C. Vincent, D. Schmitt, J. Davoust, et al. 2000. Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity 12: 71-81.
8. Douillard, P., P. Stoitzner, C. H. Tripp, V. Clair-Moninot, S. Aït-Yahia, A. D. McLellan, A. Eggert, N. Romani, and S. Saeland. 2005. Mouse lymphoid tissue contains distinct subsets of langerin/CD207 dendritic cells, only one of which represents epidermal-derived Langerhans cells. J. Invest. Dermatol. 125: 983-994.
9. Bennett, C. L., E. van Rijn, S. Jung, K. Inaba, R. M. Steinman, M. L. Kapsenberg, and B. E. Clausen. 2005. Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity. J. Cell Biol. 169: 569-576.
10. Kissenpfennig, A., S. Henri, B. Dubois, C. Laplace-Builhé, P. Perrin, N. Romani, C. H. Tripp, P. Douillard, L. Leserman, D. Kaiserlian, et al. 2005. Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity 22: 643-654.
11. Bursch, L. S., L. Wang, B. Igyarto, A. Kissenpfennig, B. Malissen, D. H. Kaplan, and K. A. Hogquist. 2007. Identification of a novel population of Langerin+ dendritic cells. J. Exp. Med. 204: 3147-3156.
12. + dendritic cells survey the skin in the steady state. J. Exp. Med. 204: 3133-3146.
13. + dendritic cells that develop and function independently of epidermal Langerhans cells. J. Exp. Med. 204: 3119-3131.
14. + dermal dendritic cells cross-present keratinocyte-derived antigens irrespective of the presence of Langerhans cells. J. Exp. Med. 207: 189-206.
15. + T cells in experimental leishmaniasis is initiated by different dendritic cell subtypes. J. Immunol. 182: 774-783.
16. + dendritic cells. Nat. Immunol. 10: 488-495.
17. Chen, C. A., M. C. Chang, W. Z. Sun, Y. L. Chen, Y. C. Chiang, C. Y. Hsieh, S. M. Chen, P. N. Hsiao, and W. F. Cheng. 2009. Noncarrier naked antigen-specific DNA vaccine generates potent antigen-specific immunologic responses and antitumor effects. Gene Ther. 16: 776-787.
18. Hung, C. F., A. Monie, R. D. Alvarez, and T. C. Wu. 2007. DNA vaccines for cervical cancer: from bench to bedside. Exp. Mol. Med. 39: 679-689.
19. + T-cell immune responses leading to therapeutic antitumor effects. Gene Ther. 15: 1156-1166.
20. + T cell responses and antitumor effects generated by DNA vaccine administered through gene gun, biojector, and syringe. Vaccine 21: 4036-4042.
21. + T cell responses in gene gun DNA immunization. J. Immunol. 167: 5549-5557.
22. Larregina, A. T., S. C. Watkins, G. Erdos, L. A. Spencer, W. J. Storkus, D. Beer Stolz, and L. D. Falo, Jr. 2001. Direct transfection and activation of human cutaneous dendritic cells. Gene Ther. 8: 608-617.
23. Morita, A., K. Ariizumi, R. Ritter, III, J. V. Jester, T. Kumamoto, S. A. Johnston, and A. Takashima. 2001. Development of a Langerhans cell-targeted gene therapy format using a dendritic cell-specific promoter. Gene Ther. 8: 1729-1737. (Pubitemid 34030707)
24. + T cells after gene gun immunization. J. Exp. Med. 188: 1075-1082.
25. Rock, K. L., and L. Shen. 2005. Cross-presentation: underlying mechanisms and role in immune surveillance. Immunol. Rev. 207: 166-183.
26. Sudowe, S., S. Dominitzki, E. Montermann, M. Bros, S. Grabbe, and A. B. Reske-Kunz. 2009. Uptake and presentation of exogenous antigen and presentation of endogenously produced antigen by skin dendritic cells represent equivalent pathways for the priming of cellular immune responses following biolistic DNA immunization. Immunology 128(1, Suppl.): e193-e205.
27. Gurunathan, S., D. M. Klinman, and R. A. Seder. 2000. DNA vaccines: immunology, application, and optimization. Annu. Rev. Immunol. 18: 927-974.
28. Stoecklinger, A., I. Grieshuber, S. Scheiblhofer, R. Weiss, U. Ritter, A. Kissenpfennig, B. Malissen, N. Romani, F. Koch, F. Ferreira, et al. 2007. Epidermal langerhans cells are dispensable for humoral and cell-mediated immunity elicited by gene gun immunization. J. Immunol. 179: 886-893.
29. Weiss, R., S. Scheiblhofer, J. Freund, F. Ferreira, I. Livey, and J. Thalhamer. 2002. Gene gun bombardment with gold particles displays a particular Th2-promoting signal that over-rules the Th1-inducing effect of immunostimulatory CpG motifs in DNA vaccines. Vaccine 20: 3148-3154.
30. Brtko, J., S. Mostböck, S. Scheiblhofer, A. Hartl, and J. Thalhamer. 1999. DNA immunization is associated with increased activity of type I iodothyronine 5′-deiodinase in mouse liver. Mol. Cell. Endocrinol. 152: 85-89.
31. Hartmann, G., R. D. Weeratna, Z. K. Ballas, P. Payette, S. Blackwell, I. Suparto, W. L. Rasmussen, M. Waldschmidt, D. Sajuthi, R. H. Purcell, et al. 2000. Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo. J. Immunol. 164: 1617-1624.
32. Overwijk, W. W., D. R. Surman, K. Tsung, and N. P. Restifo. 1997. Identification of a Kb-restricted CTL epitope of β-galactosidase: potential use in development of immunization protocols for "self" antigens. Methods 12: 117-123.
33. + T cells. J. Immunol. 171: 17-21.
34. + dendritic cells but not by Langerhans cells. Science 301: 1925-1928.
35. + dendritic cells are critical for cross-priming and IL-12 production in response to systemic antigens. J. Immunol. 183: 7732-7742.
36. Stoitzner, P., L. K. Green, J. Y. Jung, K. M. Price, C. H. Tripp, B. Malissen, A. Kissenpfennig, I. F. Hermans, and F. Ronchese. 2008. Tumor immunotherapy by epicutaneous immunization requires Langerhans cells. J. Immunol. 180: 1991-1998.
37. Black, C. A. 1999. Delayed type hypersensitivity: current theories with an historic perspective. Dermatol. Online J. 5: 7.
38. Alvarez, D., G. Harder, R. Fattouh, J. Sun, S. Goncharova, M. R. Stämpfli, A. J. Coyle, J. L. Bramson, and M. Jordana. 2005. Cutaneous antigen priming via gene gun leads to skin-selective Th2 immune-inflammatory responses. J. Immunol. 174: 1664-1674.
39. Scheiblhofer, S., A. Stoecklinger, C. Gruber, C. Hauser-Kronberger, B. Alinger, P. Hammerl, J. Thalhamer, and R. Weiss. 2007. Gene gun immunization with clinically relevant allergens aggravates allergen induced pathology and is contra-indicated for allergen immunotherapy. Mol. Immunol. 44: 1879-1887.
40. Sudowe, S., I. Ludwig-Portugall, E. Montermann, R. Ross, and A. B. Reske-Kunz. 2006. Prophylactic and therapeutic intervention in IgE responses by biolistic DNA vaccination primarily targeting dendritic cells. J. Allergy Clin. Immunol. 117: 196-203.
41. Kaplan, D. H., M. C. Jenison, S. Saeland, W. D. Shlomchik, and M. J. Shlomchik. 2005. Epidermal Langerhans cell-deficient mice develop enhanced contact hypersensitivity. Immunity 23: 611-620.
42. Bennett, C. L., M. Noordegraaf, C. A. Martina, and B. E. Clausen. 2007. Langerhans cells are required for efficient presentation of topically applied hapten to T cells. J. Immunol. 179: 6830-6835.
43. - but not plasmacytoid dendritic cells. J. Exp. Med. 205: 1621-1634.
44. Bursch, L. S., B. E. Rich, and K. A. Hogquist. 2009. Langerhans cells are not required for the CD8 T cell response to epidermal self-antigens. J. Immunol. 182: 4657-4664.
45. Wang, L., S. C. Jameson, and K. A. Hogquist. 2009. Epidermal Langerhans cells are not required for UV-induced immunosuppression. J. Immunol. 183: 5548-5553.
46. Choi, J. H., Y. Do, C. Cheong, H. Koh, S. B. Boscardin, Y. S. Oh, L. Bozzacco, C. Trumpfheller, C. G. Park, and R. M. Steinman. 2009. Identification of antigen-presenting dendritic cells in mouse aorta and cardiac valves. J. Exp. Med. 206: 497-505.
47. + T cell survival controlled by clonal abundance. Science 312: 114-116.
48. Allan, R. S., J. Waithman, S. Bedoui, C. M. Jones, J. A. Villadangos, Y. Zhan, A. M. Lew, K. Shortman, W. R. Heath, and F. R. Carbone. 2006. Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming. Immunity 25: 153-162.
49. Cheong, C., J. Idoyaga, Y. Do, M. Pack, S. H. Park, H. Lee, Y. S. Kang, J. H. Choi, J. Y. Kim, A. Bonito, et al. 2007. Production of monoclonal antibodies that recognize the extracellular domain of mouse langerin/CD207. J. Immunol. Methods 324: 48-62.
50. Flacher, V., P. Douillard, S. Aït-Yahia, P. Stoitzner, V. Clair-Moninot, N. Romani, and S. Saeland. 2008. Expression of langerin/CD207 reveals dendritic cell heterogeneity between inbred mouse strains. Immunology 123: 339-347. (Pubitemid 351171198)
51. Nagao, K., F. Ginhoux, W. W. Leitner, S. Motegi, C. L. Bennett, B. E. Clausen, M. Merad, and M. C. Udey. 2009. Murine epidermal Langerhans cells and langerin-expressing dermal dendritic cells are unrelated and exhibit distinct functions. Proc. Natl. Acad. Sci. USA 106: 3312-3317.